Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus rhamnosus GG and Reduced Colic Symptoms

Doses used in studies

CFU/day: 10 billion (median 10 billion, IQR 10 billion–10 billion) — 1 study

Time to effect

Median: 6.1 months · IQR 6.1 months–6.1 months · Range 6.1 months–6.1 months — Reported in 1 of 1 study

1 of 1 paper

Pilot Analysis of Early Lactobacillus rhamnosus GG for Infant Colic Prevention.
- 2019-01
- RCT · n = 184
- Journal of pediatric gastroenterology and nutrition 68(1)
- - Michael D Cabana
  - Michelle McKean
  - Amy L Beck
  - Valerie Flaherman
- PubMed: 30052571
- DOI: 10.1097/mpg.0000000000002113
2 Insights on
- Reduced Colic Symptoms
- High evidence
- Large Human Trial
- Infants
There were no differences between the 2 groups in the percentage of infants with colic based on symptoms (control 5.4% vs LGG 9.8%; P=0.19)
Effect
Neutral
Effect size
Small
Significant
No
Dose
10 billion colony-forming units (CFU) daily